SpaceX is moving toward a public-market debut so large that it is less a routine listing than a stress test for the growth-stock complex. The company is aiming to raise…
The Finance Herald
Samsung Electronics has delivered a powerful signal that the artificial intelligence buildout is reshaping the memory-chip cycle, but its record quarter also raises a harder question for investors: whether extraordinary…
Rio Tinto’s first-half results give investors a different read on the artificial-intelligence buildout than the one coming from chip stocks. The miner is not selling servers or software, but its…
Mercedes-Benz has given investors a mixed but useful read on the state of global luxury autos: the group can still defend earnings with vans, finance and cost reductions, but its…
The Federal Reserve enters this week’s policy meeting with an unusual problem: investors are not simply debating whether rates are high enough, they are debating how much guidance the central…
Kuwait’s $16 billion pipeline agreement with Blackstone, Brookfield and KKR is more than a large infrastructure financing. It is a test of whether Gulf energy states can use private capital…
American Express gave investors a clean read on one of the more important questions in consumer finance: affluent cardholders are still spending, but the cost of keeping them loyal is…
Nestle’s half-year results gave investors a useful reminder that even the world’s largest packaged-food company cannot restructure itself without visible strain. The Swiss group reported improving organic sales momentum and…
Tesla’s second-quarter report gave investors the two things they have been waiting to see from the electric-vehicle maker: stronger demand for cars and more evidence that Elon Musk is moving…
UK inflation fell faster than expected in June, giving Prime Minister Andy Burnham an early economic tailwind but leaving investors with a more complicated question: whether a softer headline number…
Tempus AI’s agreement to acquire Personalis gives investors a clean view of what the market now wants from healthcare artificial intelligence: not more ambition, but evidence that data, diagnostics and…